GC376 sodium

CAS No. 1416992-39-6

GC376 sodium ( —— )

Catalog No. M19959 CAS No. 1416992-39-6

GC376 is an inhibitor of 3C-like proteases (3CLpro) with IC50 values range from 0.49~4.35 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 83 In Stock
10MG 120 In Stock
25MG 167 In Stock
50MG 259 In Stock
100MG 390 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GC376 sodium
  • Note
    Research use only not for human use.
  • Brief Description
    GC376 is an inhibitor of 3C-like proteases (3CLpro) with IC50 values range from 0.49~4.35 μM.
  • Description
    GC376 is an inhibitor of 3C-like proteases (3CLpro) with IC50 values range from 0.49~4.35 μM.
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Antifection
  • Recptor
    3CLpro
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1416992-39-6
  • Formula Weight
    507.53
  • Molecular Formula
    C21H30N3NaO8S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    [Na+].CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC1CCNC1=O)C(O)S([O-])(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kim Y et al. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses noroviruses and coronaviruses. J Virol. 2012 Nov;86(21):11754-62.
molnova catalog
related products
  • Niranthin

    Niranthin is a potent anti-leishmanial agent, inhibits the relaxation activity of heterodimeric type IB topoisomerase of L. donovani and acts as a non-competitive inhibitor interacting with both subunits of the enzyme. Niranthin also exhibits anti-hepatitis B virus, antiinflammatory and antiallodynic actions.

  • Colutehydroquinone

    Colutehydroquinone is an antifungal isoflavonoid from Colutea arborescens.

  • 2-Furoic acid

    2-Furoic acid an orally active selective human cathepsin K inhibitor may have the therapeutic potential for the treatment of diseases characterized by excessive bone loss including osteoporosis.Furan-2-carboxylic acid also has anti-bacterial effect.